![Matthias Guckenberger: Cancer trial participation not associated with longer OS compared to routine care](https://oncodaily.com/pub/uploads/2024/06/IMG_3327-1-1280x548.jpeg)
Jun 18, 2024, 18:23
Matthias Guckenberger: Cancer trial participation not associated with longer OS compared to routine care
Matthias Guckenberger, Radiation Oncologist at University Hospital Zurich, shared on X:
“Cancer trial participation not associated with longer OS compared to routine care.
Motivation for patients:
- Potential benefits other than OS eg structured care protocols.
- To contribute to a better treatment for FUTURE patients.”
Additional information.
Source: Matthias Guckenberger/X